Therapy News and Research

RSS

bit.bio appoints Kathryn Corzo as Chief Operating Officer

Cell coding company bit.bio today announces the key appointment of Kathryn Corzo as Chief Operating Officer. She started in the role on 1 November 2021.

From bit.bio 19 Nov 2021

Severe COVID-19 patients have significantly higher NK and T cell frequency

A new study published in the open-access journal Cells aimed to clarify the role of NK and T cell subsets in SARS-CoV-2 infection in hospitalized COVID-19 patients to unravel their potential association with disease severity.

18 Nov 2021

One in four adults with ADHD found to have generalized anxiety disorder

A new nationally representative study published online in the Journal of Affective Disorders found that one in four adults aged 20-39 with attention deficit hyperactivity disorder (ADHD) had generalized anxiety disorder (GAD).

18 Nov 2021

CHEST and AAHomecare release new toolkit to support patients who require supplemental oxygen

The American College of Chest Physicians and The American Association for Homecare (AAHomecare) are releasing an Oxygen Toolkit supporting individuals who require supplemental oxygen and clinicians who prescribe supplemental oxygen to their patients.

18 Nov 2021

New test enables patient-specific monitoring and treatment for ovarian cancer

Around 870 cases of ovarian cancer are reported in Belgium every year. Most of these patients are treated with surgical interventions and/or chemotherapy.

18 Nov 2021

New trial demonstrates stable coagulation factor VIII in hemophilia A patients after gene therapy

A novel gene therapy for hemophilia A led to sustained expression of the clotting factor those patients lack, resulting in a reduction – or in some cases complete elimination – of painful and potentially life-threatening bleeding events, according to a new study led by researchers at Children's Hospital of Philadelphia.

18 Nov 2021

REGEN-COV is effective in preventing severe COVID-19 in immunocompromised individuals

A recent study assesses the efficacy of repeat doses of REGEN-COV in SARS-CoV-2-negative adults who were healthy or had chronic medical conditions.

18 Nov 2021

New mothers' placenta could help reduce brain injury in other growth-restricted babies

The placenta from mothers of healthy newborns could one day be used to reduce brain injury in growth-restricted babies, according to University of Queensland research.

18 Nov 2021

Antiretroviral drugs detected in drinking water

Years ago, there was a time that kids from a rural village in South Africa still wanted to swim in the rivers nearby. But when they got out of the water, those with sensitive skins would have the worst rash ever, says Prof Philiswa Nomngongo.

18 Nov 2021

Short-term severe calorie restriction safe, feasible, and well tolerated by cancer patients

A diet involving short-term, severe calorie restriction was safe, feasible, and resulted in a decrease of blood glucose and growth factor concentration, reduction in peripheral blood immunosuppressive cells, and enhanced intratumor T-cell infiltration in cancer patients receiving standard-of-care therapy, according to the results of a clinical trial.

18 Nov 2021

Researchers develop a new way of coupling biomaterials to living cells

A fully new way of coupling biomaterials to living cells, developed by the University of Twente, enables us to teach the body new things.

18 Nov 2021

Experts develop a functional precision medicine approach to assign therapies to cancer patients

A functional precision medicine study conducted in Finland demonstrates that treatment selection based on results from drug sensitivity testing of patients' cells can be clinically useful in patients with aggressive hematological cancers.

18 Nov 2021

Blood proteomic survey in undiagnosed population with COVID-19

In this study, scientists have profiled 276 circulating proteins that are associated with cardiovascular and metabolic functions.

18 Nov 2021

Study shows neutralizing capacity of monoclonal antibodies against SARS-CoV-2 variants of concern

Canadian public health researchers recently published a study in the journal Antiviral Research wherein they described generating a panel of murine hybridomas recognizing SARS-CoV-2 spike protein or nucleoprotein, capable of neutralizing the SARS-CoV-2 variants of concern, proving their therapeutic potential.

17 Nov 2021

Researchers identify compounds that tackle fungal infections in a new way

Current medications aren't particularly effective against fungi. The situation is becoming more challenging because these organisms are developing resistance to antimicrobial treatments, just as bacteria are.

17 Nov 2021

Inhaled prostacyclin improves oxygenation in acute respiratory distress syndrome patients

The findings reveal that inhaled prostacyclin significantly improves oxygenation in ARDS patients who had COVID-19. The study is currently available on the medRxiv* preprint server.

17 Nov 2021

Study may help predict genomic changes that may happen in advanced cancers based on therapy

A novel way to look at cancer treatment resistance offers the possibility for identifying genetic mechanisms involved and alternative treatment approaches.

17 Nov 2021

SARS-CoV-2-related smell loss lasts longer than previously thought

A recent study discusses the long-term prevalence of olfactory dysfunction in COVID-19 patients.

17 Nov 2021

New technology could revolutionize treatment of pediatric burns

Burns are one of the most common injuries suffered by Australians and one of the top causes of death in children under four. While survival rates for burns patients have improved substantially, treating paediatric burns remains challenging, especially with the rise of multi-drug resistant bacteria.

17 Nov 2021

Young adults with cancer may require different treatments than older patients

Not all tumors are alike. Young adults who are diagnosed with skin, colon, and other cancer types may require different treatments than older patients receive.

16 Nov 2021

Therapy News and Research

bit.bio appoints Kathryn Corzo as Chief Operating Officer

Severe COVID-19 patients have significantly higher NK and T cell frequency

One in four adults with ADHD found to have generalized anxiety disorder

CHEST and AAHomecare release new toolkit to support patients who require supplemental oxygen

New test enables patient-specific monitoring and treatment for ovarian cancer

New trial demonstrates stable coagulation factor VIII in hemophilia A patients after gene therapy

REGEN-COV is effective in preventing severe COVID-19 in immunocompromised individuals

New mothers' placenta could help reduce brain injury in other growth-restricted babies

Antiretroviral drugs detected in drinking water

Short-term severe calorie restriction safe, feasible, and well tolerated by cancer patients

Researchers develop a new way of coupling biomaterials to living cells

Experts develop a functional precision medicine approach to assign therapies to cancer patients

Blood proteomic survey in undiagnosed population with COVID-19

Study shows neutralizing capacity of monoclonal antibodies against SARS-CoV-2 variants of concern

Researchers identify compounds that tackle fungal infections in a new way

Inhaled prostacyclin improves oxygenation in acute respiratory distress syndrome patients

Study may help predict genomic changes that may happen in advanced cancers based on therapy

SARS-CoV-2-related smell loss lasts longer than previously thought

New technology could revolutionize treatment of pediatric burns

Young adults with cancer may require different treatments than older patients

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News